Johnson & Johnson MedTech today announced the launch of the KINCISE 2 Surgical Automated System, an automated power tool that could offer improvements over manual impaction across both primary and revision hip, and revision knee replacement procedures.
KINCISE 2 builds on the functionality of the company's first-generation KINCISE System and adds new design features—including increased reverse energy and push to lock adaptors. The newest addition of Acetabular Cup Extraction makes the KINCISE 2 System the first and only automated impactor approved for removing well-fixed acetabular components, the company said.
“The KINCISE 2 System exemplifies the needs-based innovation we’re bringing to Orthopedics this year,” said Aldo Denti, Company Group Chairman, Orthopedics, Johnson & Johnson MedTech. “As more patients undergo joint replacements earlier in life, the demand for revision surgeries is rising. The KINCISE System has demonstrated the ability to help surgeons manage those complex cases by reducing operating time and providing procedural control – ultimately supporting better outcomes for patients.”
The system is now commercially available in the United States.
